Granisetron HCL Tablets

Product/Composition Granisetron HCL Tablets
Strength 1mg
Form Tablets
Production Capacity 10 Million Tablets/Month
Packaging 5 X 10 Tablets / Box
Therapeutic use Anti Cancer
Package Insert/Leaflet Available upon request

Granisetron HCl Tablets are a medicine used to prevent nausea and vomiting, particularly those caused by chemotherapy, radiation therapy, or surgery. They belong to a class of drugs called 5-HT3 receptor antagonists.

Here are the key details:

  • Composition: Each tablet contains Granisetron hydrochloride, commonly in strengths such as 1 mg or 2 mg.

  • Dosage Form: Oral tablets, usually taken once or twice daily, as prescribed by a doctor.

  • Mode of Action:

    • Granisetron blocks serotonin (5-HT3) receptors in the brain and gastrointestinal tract.

    • This prevents the activation of the vomiting reflex, reducing nausea and vomiting.

  • Uses:

    • Chemotherapy-induced nausea and vomiting (CINV).

    • Radiation-induced nausea and vomiting (RINV).

    • Postoperative nausea and vomiting (PONV) after surgery.

  • Treatment Goal: To prevent or control nausea and vomiting, improving patient comfort and adherence to treatment.

  • Side Effects:

    • Common: headache, constipation, dizziness, fatigue.

    • Less common/serious: allergic reactions, irregular heartbeat, severe dizziness, low blood pressure.

  • Precautions:

    • Use caution in patients with heart rhythm disorders.

    • Inform the doctor about other medications, especially those affecting heart rhythm.

    • Not recommended during pregnancy or breastfeeding unless prescribed.

    • Adequate hydration and monitoring may be advised during chemotherapy or post-surgery.

👉 Granisetron HCl is effective for preventing nausea and vomiting by blocking serotonin signals that trigger the vomiting reflex, making it widely used in oncology and surgical settings.